Effects of oral androstenedione on steroid metabolism in liver of pregnant and non-pregnant female rats

It is unknown whether androstenedione, a steroidal dietary supplement taken to enhance athletic performance, can affect physiological hormone levels by altering liver enzyme activities that metabolize steroid hormones. Altered hormone levels could be especially devastating during pregnancy. Mature f...

Full description

Saved in:
Bibliographic Details
Published in:Food and chemical toxicology 2005-04, Vol.43 (4), p.537-542
Main Authors: Flynn, T.J., Sapienza, P.P., Wiesenfeld, P.W., Ross, I.A., Sahu, S., Kim, C.S., O’Donnell, M.W., Collins, T.F.X., Sprando, R.L.
Format: Article
Language:English
Subjects:
Administration, Oral
adverse effects
Androstenedione
Androstenedione - administration & dosage
Androstenedione - pharmacology
Animals
Biological and medical sciences
cytochrome P-450
Cytochrome P-450 Enzyme System - pharmacology
Cytochromes P450
dosage
Endocrine disruption
endocrine-disrupting chemicals
ergogenic aids
Female
gestational age
hepatotoxicity
hormone metabolism
hormone supplements
Liver
Liver - drug effects
Liver - physiology
liver microsomes
maternal nutrition
Medical sciences
nutrient-drug interactions
Pregnancy
pregnancy outcome
pregnant women
Rats
Steroids
Steroids - metabolism
Toxicology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:It is unknown whether androstenedione, a steroidal dietary supplement taken to enhance athletic performance, can affect physiological hormone levels by altering liver enzyme activities that metabolize steroid hormones. Altered hormone levels could be especially devastating during pregnancy. Mature female rats were gavaged with 0, 5, 30 or 60 mg/kg/day androstenedione beginning two weeks prior to mating and continuing through gestation day 19. Non-pregnant female rats were gavaged over the same time frame with 0 or 60 mg/kg/day androstenedione. Livers were removed from dams on gestation day 20 and from non-pregnant rats after five weeks’ treatment. Liver microsomes were incubated with 200 μM testosterone, and the reaction products were isolated and analyzed by HPLC. In pregnant rats, formation of 6α-, 15β-, 7α-, 16β-, and 2β-hydroxytestosterone was increased significantly vs. control at the highest dose level only. Formation of 6β-hydroxytestosterone increased significantly at both the 30 and 60 mg/kg/day dose levels. In non-pregnant rats, 60 mg/kg/day androstenedione significantly increased formation of 15β-, 6β-, 16β-, and 2β-hydroxytestosterone. The data suggest that high oral doses of androstenedione can induce some female rat liver cytochromes P450 that metabolize steroid hormones and that the response to androstenedione does not differ between pregnant and non-pregnant female rats.
ISSN:0278-6915
1873-6351
DOI:10.1016/j.fct.2004.12.007